Annual Secretarial Compliance Report as per prescribed format.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted a revised Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under Regulation 24A of SEBI's Listing Regulations. The Practicing Company Secretary, G. Vinay Babu, examined the company's filings, website, and records for compliance with SEBI Act, SCRA, and various SEBI regulations. The report confirms the company has fully complied with all applicable provisions, with no deviations, no penalties, and no fines during the review period. Additionally, all 13 specific compliance areas including Secretarial Standards, insider trading, related party transactions, and corporate governance disclosures were met satisfactorily.
This is a routine regulatory compliance filing with no material business impact. Clean compliance status with no penalties or regulatory actions is a neutral-to-slightly-positive signal for shareholders, confirming good governance practices, but is unlikely to move the stock price.